Zentalis Pharmaceuticals, Inc. (ZNTL)
$3.76-1.83%Close
SELLCRISIS · day 12
Key stats
- Market cap
- $268M
- Avg volume
- 1.2M
- Beta
- 1.89
- P/E (TTM)
- -1.53
- 1W
- +1.35%
- 1M
- -13.16%
- 3M
- -7.39%
- YTD
- +174.45%
- vs SPY 1W
- +2.54%
- vs SPY 1M
- -16.48%
- vs SPY 3M
- -9.78%
- vs SPY YTD
- +162.70%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- COGTSELLCogent Biosciences, Inc.BEARQ 14$36.23-1.36%
- DRTSBUYAlpha Tau Medical Ltd.BULLQ 16$14.70-1.47%
- NXTCBUYNextCure, Inc.CRISISQ -7$5.89-6.36%
- NRCBUYNational Research CorporationRECOVERYQ 3$21.92-1.22%
- DCOYSELLDecoy Therapeutics Inc.CRISISQ -24$3.11-2.81%
- ZJYLBUYJin Medical International Ltd.CRISISQ 4$3.04+0.00%
- AARDSELLAardvark Therapeutics, Inc. Common StockRECOVERYQ -15$6.88+0.88%
- AGMBBUYAgomAb Therapeutics N.V. American Depositary SharesQ -8$12.82-3.25%
- INTSBUYIntensity Therapeutics, Inc.RECOVERYQ -17$4.75-2.26%
- CRLBUYCharles River Laboratories International, Inc.BULLQ 12$298.58+1.15%
- PLSMSELLPulsenmore Ltd. Ordinary SharesQ -32$2.79-5.10%
- RXSTBUYRxSight, Inc.BEARQ -10$6.26+0.16%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 17
- VALUE
- 6
- GROWTH
- 45
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-52.8%
REV YoY-
ROE-88.0%
EPS YoY-
ROA-81.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.53
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.84
P/FCF-
EV/EBITDA-1.62
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E26.24
ALTMAN Z-
CURR RATIO4.82
ND/EBITDA-
BETA1.89
